Compare SVV & CMPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SVV | CMPS |
|---|---|---|
| Founded | 1954 | 2020 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.2B |
| IPO Year | 2021 | 2020 |
| Metric | SVV | CMPS |
|---|---|---|
| Price | $10.81 | $13.39 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 8 |
| Target Price | $13.67 | ★ $25.38 |
| AVG Volume (30 Days) | 1.4M | ★ 3.5M |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.10 | N/A |
| Revenue | ★ $1,678,954,000.00 | N/A |
| Revenue This Year | $6.91 | N/A |
| Revenue Next Year | $7.80 | N/A |
| P/E Ratio | $107.10 | ★ N/A |
| Revenue Growth | ★ 9.19 | N/A |
| 52 Week Low | $6.91 | $3.97 |
| 52 Week High | $13.89 | $15.40 |
| Indicator | SVV | CMPS |
|---|---|---|
| Relative Strength Index (RSI) | 54.21 | 57.42 |
| Support Level | $9.14 | $10.66 |
| Resistance Level | $11.38 | $14.92 |
| Average True Range (ATR) | 0.63 | 0.75 |
| MACD | 0.06 | 0.24 |
| Stochastic Oscillator | 49.18 | 72.13 |
Savers Value Village Inc is a for-profit thrift operator in the United States and Canada. It purchases second-hand textiles (i.e., clothing, bedding, and bath items), shoes, accessories, housewares, books, and other goods from its non-profit partners (NPPs), either directly from them or via on-site donations (OSDs) at Community Donation Centers at its stores. The company then processes, selects, prices, and sells these items in its stores.
Compass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions. Its research centers on a proprietary synthetic psilocybin formulation, COMP360, which is administered alongside psychological support. The company is conducting clinical trials to evaluate the safety and efficacy of this treatment in patients with treatment-resistant depression and other mental health disorders. The company operates in one operating segment.